We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
- Authors
Shaw, Briony; Shortt, Jake; Low, Michael; Rogers, Benjamin; Kaplan, Zane; Fedele, Pasquale; Gregory, Gareth; Vilcassim, Shahla; Gilbertson, Michael; Grigoriadis, George; Opat, Stephen
- Abstract
Coronavirus disease 2019 (COVID-19) infection in patients with haematological neoplasms has been associated with increased mortality; however, many studies in this patient group were reported early in the pandemic. The authors evaluated outcomes of COVID-19 infection in patients with haematological conditions following widespread vaccination, newer viral variants and increasingly effective antiviral therapies. A 4% mortality rate was found and contemporary risk factors for hospitalisation including older age, nonvaccination or partial COVID-19 vaccination status and infection with non-Omicron strain were identified.
- Subjects
COVID-19; CONFIDENCE intervals; COVID-19 vaccines; IMMUNOCOMPROMISED patients; AGE distribution; DEXAMETHASONE; ANTIVIRAL agents; CANCER patients; RISK assessment; HEMATOLOGIC malignancies; HOSPITAL care; MESSENGER RNA; CHI-squared test; DESCRIPTIVE statistics; RESEARCH funding; VACCINATION status
- Publication
Internal Medicine Journal, 2022, Vol 52, Issue 12, p2172
- ISSN
1444-0903
- Publication type
Article
- DOI
10.1111/imj.15954